Brief: Tenax Therapeutics Inc - Co And Orion Amend License Agreement - SEC Filing
09/09/2025 13:14
Sept 9 (Reuters) - Tenax Therapeutics Inc TENX.O: TENAX THERAPEUTICS INC - CO AND ORION AMEND LICENSE AGREEMENT - SEC FILING TENAX THERAPEUTICS INC - UNDER AMENDMENT, GAINS EXCLUSIVE WORLDWIDE RIGHTS FOR LEVOSIMENDAN PRODUCTS - SEC FILING TENAX THERAPEUTICS INC - ORION TO SUPPLY LEVOSIMENDAN FOR TENAX'S ORAL PRODUCT MANUFACTURING - SEC FILING Further company coverage: TENX.O ((Reuters.Briefs@thomsonreuters.com;))